Jun 23, 2026 08:03AM
May 7, 2026 05:13PM
May 5, 2026 04:00PM
Mar 30, 2026 04:00PM
Mar 11, 2026 06:05AM
Feb 19, 2026 12:16PM
Feb 12, 2026 07:01AM INmune Bio receives FDA alignment on phase 2b/3 trial design for alzheimer's drug
Feb 10, 2026 08:04AM
Jan 27, 2026 09:25AM
Oct 30, 2025 04:23PM
Aug 7, 2025 05:44PM
Aug 4, 2025 12:13PM
Aug 4, 2025 08:14AM
Jun 30, 2025 04:37PM BTIG Downgrades INmune Bio Inc. (INMB) to Neutral
Jun 30, 2025 04:01PM
Jun 30, 2025 02:24PM
Jun 30, 2025 01:49PM
Jun 30, 2025 10:36AM
Jun 30, 2025 07:30AM
Jun 27, 2025 12:16PM
Jun 26, 2025 04:42PM After-hours movers: Nike, American Outdoor Brands and more
Jun 26, 2025 04:01PM
Jun 24, 2025 10:47AM
Jun 23, 2025 10:53AM
Jun 10, 2025 04:02PM
Jun 4, 2025 06:18AM
May 8, 2025 04:14PM
Apr 16, 2025 07:01AM INmune Bio (INMB) Receives Favorable Patentability Opinion for CORDStrom Platform Technology
Apr 1, 2025 07:02AM
Mar 31, 2025 04:54AM
Feb 12, 2025 07:03AM
Feb 12, 2025 05:12AM
Feb 11, 2025 06:53AM
Feb 10, 2025 07:03AM
Jan 28, 2025 10:26AM BTIG Reiterates Buy Rating on INmune Bio Inc. (INMB)
Jan 28, 2025 08:05AM
Jan 28, 2025 06:31AM
Oct 31, 2024 04:12PM
Sep 26, 2024 08:01AM
Sep 18, 2024 09:14AM
Sep 18, 2024 06:22AM
Sep 17, 2024 08:31AM INmune Bio (INMB) Reports Results of Additional Blinded Interim Analysis of Phase 2 Alzheimer's Disease Trial
Sep 13, 2024 08:31AM
Aug 22, 2024 07:38AM
Aug 2, 2024 04:03PM
Aug 1, 2024 04:51PM
Jul 29, 2024 09:00AM
Jul 23, 2024 08:45AM

406,886 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All